(Q43812574)

27 November 2017

title

Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital (English)

1 reference

27 November 2017

K N R Chengappa

1

1 reference

27 November 2017

J Vasile

2

1 reference

27 November 2017

J Levine

3

1 reference

27 November 2017

R Ulrich

4

1 reference

27 November 2017

R Baker

5

1 reference

27 November 2017

A Gopalani

6

1 reference

27 November 2017

N Schooler

7

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

27 November 2017

published in

Schizophrenia Research

1 reference

27 November 2017

volume

53

1 reference

27 November 2017

issue

1-2

1 reference

27 November 2017

page(s)

1-6

1 reference

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

Neurobiology of D1 dopamine receptors after neonatal-6-OHDA treatment: relevance to Lesch-Nyhan disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

Clozapine antagonism of D-1 and D-2 dopamine receptor-mediated behaviors.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

Treatment of polydipsia and hyponatremia in psychiatric patients. Can clozapine be a new option?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

Clozapine treatment of borderline patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

Clozapine: strong antiaggressive effects with minimal motor impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

Clozapine as a treatment for psychosis in Parkinson's disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

Effect of clozapine on physical and verbal aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900175-4

7 January 2021

10.1016/S0920-9964(00)00175-4

Identifiers

DOI

1 reference

release_c6lj3vuvkbdzfamf6qdvo6ev24

27 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c6lj3vuvkbdzfamf6qdvo6ev24

24 November 2022

mapped directly with Wikidata item

1 reference